BASSO, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.611
EU - Europa 379
AS - Asia 283
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.274
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.608
CN - Cina 211
IT - Italia 164
FI - Finlandia 75
VN - Vietnam 51
SE - Svezia 45
DE - Germania 39
GB - Regno Unito 32
IE - Irlanda 8
IN - India 8
HK - Hong Kong 6
UA - Ucraina 6
FR - Francia 5
KH - Cambogia 3
NL - Olanda 3
BE - Belgio 2
CA - Canada 2
TR - Turchia 2
EU - Europa 1
MX - Messico 1
PH - Filippine 1
SG - Singapore 1
Totale 5.274
Salva come PNG Salva come JPEG
Città #
Fairfield 924
Woodbridge 471
Houston 431
Chandler 399
Ashburn 355
Seattle 333
Cambridge 307
Wilmington 277
Ann Arbor 230
San Diego 93
Princeton 86
Jacksonville 72
Beijing 57
Des Moines 57
Padova 57
Roxbury 51
Dong Ket 50
Medford 42
Boardman 38
Helsinki 32
Nanjing 32
Falls Church 24
Nanchang 19
Guangzhou 14
Los Angeles 14
Rome 13
London 11
Aprilia 10
Hefei 9
New York 9
Dublin 8
Hebei 8
Jiaxing 8
Tianjin 7
Hong Kong 6
Jinan 6
Norwalk 6
Santa Cruz 6
Shenyang 6
Burolo 5
Changsha 5
Kunming 5
Ningbo 5
Ogden 5
Medicina 4
Auburn Hills 3
Florence 3
Kilburn 3
Paris 3
Redmond 3
Redwood City 3
Shanghai 3
Tappahannock 3
Zhengzhou 3
Borås 2
Buffalo 2
Camponogara 2
Chiampo 2
Chicago 2
Genoa 2
Ghent 2
Indiana 2
Islington 2
Lappeenranta 2
Milan 2
Mira 2
Porto Garibaldi 2
Richland 2
San Martino Buon Albergo 2
San Polo di Piave 2
Swansea 2
Yenibosna 2
Aachen 1
Afragola 1
Almere Stad 1
Amsterdam 1
Avellino 1
Baotou 1
Camposampiero 1
Canneto 1
Castellarano 1
Cento 1
Chiswick 1
Concorezzo 1
Dallas 1
Falkenstein 1
Ferrara 1
Fuzhou 1
Genova 1
Gunzenhausen 1
Hangzhou 1
Hounslow 1
Kharkiv 1
Lanzhou 1
Las Vegas 1
Lissone 1
Miami 1
Miami Beach 1
Nanning 1
New Bedfont 1
Totale 4.698
Salva come PNG Salva come JPEG
Nome #
Viral infections of the central nervous system in elderly patients: A retrospective study 170
Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy. 161
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications 146
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 140
Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection 140
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 136
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014 135
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 125
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 124
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 116
A case of persistent bacteraemia by Ralstonia mannitolilytica and Ralstonia pickettii in an intensive care unit 113
Virological testing of cerebrospinal fluid in children aged less than 14 years with a suspected central nervous system infection: A retrospective study on 304 consecutive children from January 2012 to May 2015 112
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. 106
Peripheral blood serum markers for apoptosis and liver fibrosis: are they trustworthy indicators of liver realness? 105
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: A 24-month longitudinal study 105
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 100
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver 100
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients. 91
Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients. 90
Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension. 90
Prevalence, molecular epidemiology and intra-hospital acquisition of Klebsiella pneumoniae strains producing carbapenemases in an Italian teaching hospital from January 2015 to September 2016. 90
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 89
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer. 87
Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy. 87
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. 87
Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004–2012 in the Veneto Region, Italy 87
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin. 87
null 87
Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients. 86
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C. 85
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse. 85
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden. 83
Long-term therapy with nevirapine and tropism 83
Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C 82
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. 81
null 81
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. 79
Detection of hepatitis C virus in an exhumed body identified the origin of a nosocomial transmission that caused multiple fatal diseases 74
Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more. 74
Sustained Virological Response and Baseline Predictors in HIV-HCV Coinfected Patients Retreated with Pegylated Interferon and Ribavirin after Failing a Previous Interferon-Based Therapy: Systematic Review and Meta-Analysis 72
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects 72
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 68
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention 67
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 67
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy. 66
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant. 66
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement]. 66
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study 59
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin. 59
Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019 55
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals 54
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors 54
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumor necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 53
Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals 46
HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection 41
Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia 40
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 35
Time Course of Neutralizing Antibody in Health Care Workers with Mild or Asymptomatic COVID-19 Infection 32
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 32
Hbcab positivity is a risk factor for an increased detectability of hiv rna after switching to a two-drug regimen lamivudine-based (2dr-3tc-based) treatment: Analysis of a multicenter italian cohort 32
Viral molecular testing of cerebrospinal fluid in adults with suspected central nervous system infection in an italian university hospital laboratory: A retrospective study on 1462 consecutive patients 30
BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects 27
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 26
Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study 24
The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer. 23
Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment 21
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014 18
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection 17
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients 14
Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients. 14
Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study 5
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 5
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy 2
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 2
Totale 5.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.548
article - articoli 18.548
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019443 0 0 0 0 0 0 0 0 0 99 188 156
2019/20201.358 145 29 27 126 132 79 136 169 244 113 91 67
2020/2021888 71 77 73 97 45 33 39 112 84 68 104 85
2021/20221.094 22 150 110 42 40 42 69 83 137 21 186 192
2022/2023786 147 88 17 98 130 101 3 59 80 6 45 12
2023/2024281 17 44 46 36 21 25 32 29 8 23 0 0
Totale 5.363